bpdr fda
March 15, 2019 Approval Letter - Anti-Fyb
Mar 15, 2019 must submit a report on Form FDA 3486 to the Director, Office of Compliance and. Biologics Quality, at the following address: Food and Drug
Learn more
21 CFR 600.14 - Reporting of biological product deviations
(2) For biological products regulated by the Center for Drug Evaluation and Research (CDER), send the completed Form FDA-3486 to the Division of Compliance Risk
Learn more